Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict...

por Jongsma, Maria M E, Costes, Lea M M, Tindemans, Irma, Cozijnsen, Martinus A, Raatgreep, Rolien (H) C, van Pieterson, Merel, Li, Yunlei, Escher, Johanna C, de Ridder, Lissy, Samsom, Janneke N
Publicado 2023

Infliximab in young paediatric IBD patients: it is all about the dosing

por Jongsma, Maria M. E., Winter, Dwight A., Huynh, Hien Q., Norsa, Lorenzo, Hussey, Seamus, Kolho, Kaija-Leena, Bronsky, Jiri, Assa, Amit, Cohen, Shlomi, Lev-Tzion, Raffi, Van Biervliet, Stephanie, Rizopoulos, Dimitris, de Meij, Tim G. J., Shouval, Dror S., Wine, Eytan, Wolters, Victorien M., Martinez-Vinson, Christine, de Ridder, Lissy
Publicado 2020

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease

por Jongsma, Maria M. E., Vuijk, Stephanie A., Cozijnsen, Martinus A., van Pieterson, Merel, Norbruis, Obbe F., Groeneweg, Michael, Wolters, Victorien M., van Wering, Herbert M., Hojsak, Iva, Kolho, Kaija-Leena, van Wijk, Michiel P., Teklenburg-Roord, Sarah T. A., de Meij, Tim G. J., Escher, Johanna C., de Ridder, Lissy
Publicado 2022

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised control...

por Jongsma, Maria M E, Aardoom, Martine A, Cozijnsen, Martinus A, van Pieterson, Merel, de Meij, Tim, Groeneweg, Michael, Norbruis, Obbe F, Wolters, Victorien M, van Wering, Herbert M, Hojsak, Iva, Kolho, Kaija-Leena, Hummel, Thalia, Stapelbroek, Janneke, van der Feen, Cathelijne, van Rheenen, Patrick F, van Wijk, Michiel P, Teklenburg-Roord, Sarah T A, Schreurs, Marco W J, Rizopoulos, Dimitris, Doukas, Michail, Escher, Johanna C, Samsom, Janneke N, de Ridder, Lissy
Publicado 2022